Report
Eric Le Berrigaud

Pharmaceuticals: Hot topics at ESMO 2019

Pharmaceuticals
Hot topics at ESMO 2019

Presidential Symposiums: PARP inhibitors come first!
The end of the battle between GSK and AZ in BRCA non-mut. pts?
No groundbreaking news for PD-1/PD-L1s at the congress
Limited FV swing factors at first glance
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Eric Le Berrigaud

ResearchPool Subscriptions

Get the most out of your insights

Get in touch